WVE - Wave Life Sciences GAAP EPS of -$0.62 misses by $0.08 revenue of $0.37M
- Wave Life Sciences press release ( NASDAQ: WVE ): Q2 GAAP EPS of -$0.62 misses by $0.08 .
- Revenue of $0.37M (-86.7% Y/Y).
- As of June 30, 2022, Wave had $148.2 million in cash, cash equivalents and short-term investments
For further details see:
Wave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37M